Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Phase 3 Study
Sort By
Newest First
1 / 1
Phase 3
New DARZALEX® (daratumumab) Phase 3 Study Shows Efficacy and Safety Data of Anti-CD38 Monoclonal Antibody in Patients with Newly Diagnosed Multiple Myeloma
Janssen Pharmaceutical Companies
PR-M12-18-NI-019
Dec 06, 2018
Clinical Trials
Phase III Study Results for Peanut Allergy Therapy Are a Mixed Bag
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M11-18-NI-021
Nov 20, 2018
Clinical Trials
Regenera Pharma Enrolls First Patient in US Phase 3 Study of RPh201 in NAION, Advances Phase 2 Study in Alzheimer's Disease in Canada
Regenera Pharma
PR-M08-18-NI-038
Aug 10, 2018
1 / 1
